argenx Acquires Forte Biosciences for $2.2 Billion
argenx SE (ARGX) entered a merger agreement on July 27, 2026, to acquire Forte Biosciences, Inc. (FBRX) in a deal valued at $2.2 billion. Deal Structure: argenx, through a wholly…
Written byAsif SuriaSource: InsideArbitrage
argenx SE (ARGX) entered a merger agreement on July 27, 2026, to acquire Forte Biosciences, Inc. (FBRX) in a deal valued at $2.2 billion. Deal Structure: argenx, through a wholly owned subsidiary, will commence a cash tender offer to acquire all of the outstanding shares of Forte Biosciences’ common stock for $77 per share, representing